The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan.
Cirrhosis
Etiology
Hepatocellular carcinoma
Nationwide survey
Journal
Journal of gastroenterology
ISSN: 1435-5922
Titre abrégé: J Gastroenterol
Pays: Japan
ID NLM: 9430794
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
26
08
2020
accepted:
31
10
2020
pubmed:
22
11
2020
medline:
15
12
2021
entrez:
21
11
2020
Statut:
ppublish
Résumé
We recently reported the real-world changes in the etiologies of liver cirrhosis (LC) based on nationwide survey data and assessed the etiologies of LC with hepatocellular carcinoma (HCC). Fifty-five participants from 68 institutions provided data on 23,637 patients with HCC-complicated LC. The changing trends in etiologies were assessed. We further analyzed the data from 29 hospitals that provided the annual number of newly identified HCC-complicated LC patients from 2008 to 2016 (N = 9362) without any missing years and assessed the transition in the real number of newly identified HCC-complicated LC cases. In the overall cohort, hepatitis C virus (HCV) infection (60.3%) and hepatitis B virus (HBV) infection (12.9%) were the leading and third-most common causes of HCC-complicated LC in Japan, respectively. HCV infection was found to be the leading cause throughout Japan. The rate of viral hepatitis-related HCC decreased from 85.3 to 64.4%. Among non-viral etiologies, notable increases were observed in nonalcoholic steatohepatitis (NASH)-related HCC (from 1.5 to 7.2%) and alcoholic liver disease (ALD)-related HCC (from 8.5 to 18.6%). Regarding the real number of newly diagnosed patients, the number of patients with viral hepatitis-related HCC decreased, while the number of patients with non-viral HCC, particularly NASH-related HCC, increased. Viral hepatitis has remained the main cause of HCC in Japan. However, the decrease in viral hepatitis-related HCC, particularly HCV-related HCC highly contributed to the etiological changes. In addition, the increased incidence of non-viral HCC, particularly NASH-related HCC, was involved in the changing etiologies of HCC-complicated LC in Japan.
Sections du résumé
BACKGROUND
We recently reported the real-world changes in the etiologies of liver cirrhosis (LC) based on nationwide survey data and assessed the etiologies of LC with hepatocellular carcinoma (HCC).
METHODS
Fifty-five participants from 68 institutions provided data on 23,637 patients with HCC-complicated LC. The changing trends in etiologies were assessed. We further analyzed the data from 29 hospitals that provided the annual number of newly identified HCC-complicated LC patients from 2008 to 2016 (N = 9362) without any missing years and assessed the transition in the real number of newly identified HCC-complicated LC cases.
RESULTS
In the overall cohort, hepatitis C virus (HCV) infection (60.3%) and hepatitis B virus (HBV) infection (12.9%) were the leading and third-most common causes of HCC-complicated LC in Japan, respectively. HCV infection was found to be the leading cause throughout Japan. The rate of viral hepatitis-related HCC decreased from 85.3 to 64.4%. Among non-viral etiologies, notable increases were observed in nonalcoholic steatohepatitis (NASH)-related HCC (from 1.5 to 7.2%) and alcoholic liver disease (ALD)-related HCC (from 8.5 to 18.6%). Regarding the real number of newly diagnosed patients, the number of patients with viral hepatitis-related HCC decreased, while the number of patients with non-viral HCC, particularly NASH-related HCC, increased.
CONCLUSIONS
Viral hepatitis has remained the main cause of HCC in Japan. However, the decrease in viral hepatitis-related HCC, particularly HCV-related HCC highly contributed to the etiological changes. In addition, the increased incidence of non-viral HCC, particularly NASH-related HCC, was involved in the changing etiologies of HCC-complicated LC in Japan.
Identifiants
pubmed: 33219410
doi: 10.1007/s00535-020-01748-x
pii: 10.1007/s00535-020-01748-x
pmc: PMC7862502
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
158-167Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
Hepatol Int. 2019 Sep;13(5):587-598
pubmed: 31463665
Hepatol Res. 2020 Aug;50(8):892-923
pubmed: 32343469
Hepatol Res. 2020 Jan;50(1):15-46
pubmed: 31655492
J Gastroenterol. 2019 Sep;54(9):829-836
pubmed: 31161311
Hepatol Res. 2019 Oct;49(10):1114-1120
pubmed: 31077527
J Gastroenterol. 2010;45(1):86-94
pubmed: 19789837
Clin Gastroenterol Hepatol. 2019 Mar;17(4):748-755.e3
pubmed: 29908364
Hepatol Res. 2012 Apr;42(4):368-75
pubmed: 22151896
Gastroenterology. 2019 Jan;156(2):477-491.e1
pubmed: 30367835
JAMA. 2018 May 1;319(17):1802-1813
pubmed: 29715359
J Gastroenterol. 2011 Oct;46(10):1230-7
pubmed: 21748549
Lancet. 2019 Oct 19;394(10207):1451-1466
pubmed: 31631857
Oncology. 2002;62 Suppl 1:8-17
pubmed: 11868791
Hepatol Res. 2015 Jan;45(1):59-74
pubmed: 24965914
Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604
pubmed: 31439937
Hepatol Res. 2020 Jul;50(7):791-816
pubmed: 32343477
Lancet Gastroenterol Hepatol. 2020 Feb;5(2):167-228
pubmed: 31852635
Hepatol Res. 2019 Sep;49(9):990-1002
pubmed: 31364248
Dig Liver Dis. 2020 Jan;52(1):98-101
pubmed: 31582326
J Gastroenterol Hepatol. 2020 May;35(5):855-861
pubmed: 31609495
J Gastroenterol. 2020 Mar;55(3):353-362
pubmed: 31768801
Infection. 2020 Feb;48(1):7-17
pubmed: 31347138
Hepatol Res. 2017 May;47(6):487-496
pubmed: 28326651
J Gastroenterol. 2019 Jan;54(1):87-95
pubmed: 30203225
J Gastroenterol. 2019 Apr;54(4):367-376
pubmed: 30498904